These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 35655676)

  • 1. Active search for COVID-19 cases during integrated supportive supervision using an electronic platform to improve healthcare workers performance in Niger: the legacy of the polio eradication program.
    Haladou M; Anya BM; Oumarou B; El Khalef I; Biey JN; Harouna H; Katoto P; Wiysonge CS
    Pan Afr Med J; 2022; 41():187. PubMed ID: 35655676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leveraging Polio Geographic Information System Platforms in the African Region for Mitigating COVID-19 Contact Tracing and Surveillance Challenges: Viewpoint.
    Akpan GU; Bello IM; Touray K; Ngofa R; Oyaole DR; Maleghemi S; Babona M; Chikwanda C; Poy A; Mboussou F; Ogundiran O; Impouma B; Mihigo R; Yao NKM; Ticha JM; Tuma J; A Mohamed HF; Kanmodi K; Ejiofor NE; Kipterer JK; Manengu C; Kasolo F; Seaman V; Mkanda P
    JMIR Mhealth Uhealth; 2022 Mar; 10(3):e22544. PubMed ID: 34854813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of the Stop Transmission of Polio (STOP) program in developing countries: the experience of Kenya.
    Tesfaye B; K Makam J; Sergon K; Onuekwusi I; Muitherero C; Sowe A
    BMC Public Health; 2020 Jul; 20(1):1110. PubMed ID: 32664859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implementation of integrated supportive supervision in the context of coronavirus 19 pandemic: its effects on routine immunization and vaccine preventable surveillance diseases indicators in the East and Southern African countries.
    Bello IM; Lebo E; Shibeshi ME; Akpan GU; Chakauya J; Masresha BG; Daniel F
    Pan Afr Med J; 2021; 38():164. PubMed ID: 33995771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Community-based surveillance contribution to the response of COVID-19 in Niger.
    Maazou AA; Oumarou B; Bienvenu B; Anya BM; Didier T; Ishagh EK; Nsiari-Muzeyi BJ; Katoto P; Wiysonge CS
    Pan Afr Med J; 2021; 40():88. PubMed ID: 34909077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polio eradication in Nigeria: evaluation of the quality of acute flaccid paralysis surveillance documentation in Bauchi state, 2016.
    Ningi AI; Shuaib F; Ibrahim LM; Saleh JA; Abdelrahim K; Bello IM; Abba B; Muluh TJ; Braka F; Tegegne SG; Wallah A; Korir C; Bawa S; Saidu M; Nsubuga P
    BMC Public Health; 2018 Dec; 18(Suppl 4):1307. PubMed ID: 30541495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of COVID-19 Pandemic on Global Poliovirus Surveillance.
    Zomahoun DJ; Burman AL; Snider CJ; Chauvin C; Gardner T; Lickness JS; Ahmed JA; Diop O; Gerber S; Anand A
    MMWR Morb Mortal Wkly Rep; 2021 Jan; 69(5152):1648-1652. PubMed ID: 33382673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Effect of Real Time Integrated Supportive Supervision Visits on the Performance of Health Workers in Zambia.
    Umar AS; Bello IM; Okeibunor JC; Mkanda P; Akpan GU; Manyanya D; Eshetu SM; Brine M; Belem M; Penelope M; Fussum D
    J Immunol Sci; 2021 Apr; Spec Issue(2):1114. PubMed ID: 33954307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The value of community participation in disease surveillance: a case study from Niger.
    Ndiaye SM; Quick L; Sanda O; Niandou S
    Health Promot Int; 2003 Jun; 18(2):89-98. PubMed ID: 12746380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strengthening acute flaccid paralysis surveillance post Ebola virus disease outbreak 2015 - 2017: the Liberia experience.
    Clarke A; Blidi N; Dahn B; Agbo C; Tuopileyi R; Rude MJ; Williams GS; Seid M; Gasasira A; Wambai Z; Skrip L; Nagbe T; Nyenswah T; Chukwudi JO; Johnson T; Talisuna A; Yahaya AA; Rajatonirina S; Fall IS
    Pan Afr Med J; 2019; 33(Suppl 2):2. PubMed ID: 31402963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progress towards the global eradication of poliomyelitis.
    Hull HF; Ward NA
    World Health Stat Q; 1992; 45(2-3):280-4. PubMed ID: 1462662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The contribution of the polio eradication initiative on the operations and outcomes of non-polio public health programs: a survey of programs in the African region.
    Nsubuga P; Masiira B; Ibrahim L; Ndakala N; Dongmo N
    Pan Afr Med J; 2018; 31():207. PubMed ID: 31447967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polio Eradication Initiative (PEI) contribution in strengthening public health laboratories systems in the African region.
    Gumede N; Coulibaly SO; Yahaya AA; Ndihokubwayo JB; Nsubuga P; Okeibunor J; Dosseh A; Salla M; Mihigo R; Mkanda P; Byabamazima C
    Vaccine; 2016 Oct; 34(43):5164-5169. PubMed ID: 27646028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intensified Local Resource Mobilization for the Polio Eradication Initiative: The Experience of World Health Organization in Nigeria During 2008-2015.
    Yehualashet YG; Horton J; Mkanda P; Vaz RG; Afolabi O; Gashu SG; Banda R; O'Malley H; Nsubuga P
    J Infect Dis; 2016 May; 213 Suppl 3(Suppl 3):S101-7. PubMed ID: 26912380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using the Stop Transmission of Polio (STOP) Program to Develop a South Sudan Expanded Program on Immunization Workforce.
    Tchoualeu DD; Hercules MA; Mbabazi WB; Kirbak AL; Usman A; Bizuneh K; Sandhu HS
    J Infect Dis; 2017 Jul; 216(suppl_1):S362-S367. PubMed ID: 28838163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strategic Engagement of Technical Surge Capacity for Intensified Polio Eradication Initiative in Nigeria, 2012-2015.
    Yehualashet YG; Mkanda P; Gasasira A; Erbeto T; Onimisi A; Horton J; Banda R; Tegegn SG; Ahmed H; Afolabi O; Wadda A; Vaz RG; Nsubuga P
    J Infect Dis; 2016 May; 213 Suppl 3(Suppl 3):S116-23. PubMed ID: 26912379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Interrupting the chains of transmission of COVID-19 in Italy: survey among the Prevention Departments].
    Salmaso S; Zambri F; Renzi M; Giusti A
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):33-41. PubMed ID: 33412792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adapting Nepal's polio eradication programme.
    Paudel KP; Hampton LM; Gurung S; Bohara R; Rai IK; Anaokar S; Swift RD; Cochi S
    Bull World Health Organ; 2017 Mar; 95(3):227-232. PubMed ID: 28250536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The critical role of acute flaccid paralysis surveillance in the Global Polio Eradication Initiative.
    Tangermann RH; Lamoureux C; Tallis G; Goel A
    Int Health; 2017 May; 9(3):156-163. PubMed ID: 28582560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.